Trapped by tranquility: Understanding dependence on benzodiazepines

written by Joana Mihani
edited by Nathalie Claus

Reviewers: Sofia Burmester and Abhishek Ghosh

Editorial Assistant: Zoey Chapman

Benzodiazepines offer relief from anxiety and insomnia, yet their calming effects can quietly lead to physical and psychological dependence. This piece explores how that reliance develops and why withdrawal requires support and patience. Recovery is possible when guidance, compassion, and gradual healing replace fear.

Introduction: The Double-Edged Calm

Benzodiazepines — medications like alprazolam, lorazepam, or diazepam — are among the most widely prescribed drugs worldwide. They ease anxiety, calm panic, and help people sleep [1]. Because they work quickly and bring almost immediate relief, they’re often widely prescribed— even though clinical guidelines recommend only short-term use of 2-4 weeks [2], [3]. The same soothing effect that makes them so effective can also create something more complex: a blend of psychological and physical dependence. The body can adapt to benzodiazepines, leading to tolerance (needing higher doses for the same effect) and withdrawal symptoms when use is reduced or stopped, and may feel a need to continue using the medication.

For many people, benzodiazepines arrive during a vulnerable moment — a sleepless stretch of stress, a panic attack that felt unbearable, a loss that shook stability. In that moment, the calm they provide can feel life-saving. But the brain is a quick learner: when relief consistently comes from a pill, it may gradually forget how to calm itself. What begins as temporary support can slowly shift into something that feels necessary just to get through daily life.

This article explores how that happens — how the mind begins to believe that peace is impossible without the pill, and how comfort can slowly turn into an invisible cage. The term “dependence” here is used in a broader, non-diagnostic sense; however, clinically, benzodiazepine dependence refers to a syndrome that can be diagnosed based on diagnostic manuals (e.g. ICD-10), requiring behavioral, cognitive, and physiological criteria. This article aims to understand why it’s so difficult to escape that cage of benzodiazepines — and how professional guidance, combined with compassion and understanding, can open the door to recovery.

Picture 1.

Understanding Benzodiazepine Use and the Potential for Long-Term Dependence

Benzodiazepines are commonly prescribed medications in many countries [1]. In the United States, for example, approximately 12.6% of adults reported using a benzodiazepine, with around 10.4% using them as prescribed, and about 2.2% misuse them [4]. Misuse generally refers to inappropriate use outside medical guidance [5], and it affects millions of people, which means the risk of dependence is definitely real [4]. And on top of that, even though benzodiazepines are meant to be used only for short periods of time, many people end up taking them longer than planned, which can make that risk even higher. In a Finnish national study of benzodiazepine and related drug users, about 34% of working-age adults and 55% of older adults (65+) developed long-term use (defined as continuous use for 180 days or longer) [6]. Across Europe, long-term benzodiazepine use in the general population is estimated at around 3%, but this rate is significantly higher among older adults, where approximately 24% of benzodiazepine users become long-term users [7]. Long-term use has been associated with several adverse effects, including cognitive impairment and a possible increased risk of dementia [8], as well as an increased risk of falls and fractures in older adults [9]. Among working-age individuals, long-term use is also linked to a higher likelihood of motor vehicle and workplace accidents [10]. Certain groups are at greater risk while using, including individuals who have a history of substance use disorders or comorbid dependencies (e.g., alcohol or other drugs) [11]. While side effects of long-term use are increasingly acknowledged, the issue of dependence is discussed far less — especially in low- and middle-income countries, where awareness and support may be limited [12].

Picture 2.

Forms of Benzodiazepine Dependence and How They Develop

Dependence means needing something to feel “normal,” and may be linked to a compulsion to use. With benzodiazepines, this dependence can take two main forms — physical and psychological — which often intertwine and reinforce each other.

1. Physical Dependence

Physical dependence develops when the body adapts to the medication. If the drug is stopped suddenly, withdrawal and rebound symptoms can appear. This usually happens after weeks or months of continuous use [13]. Benzodiazepines work by enhancing the effect of a natural calming chemical in the brain called GABA. This is what reduces anxiety, relaxes muscles, and can help with sleep [14]. However, when benzodiazepines are used regularly over time, the brain begins to adapt. This is what leads to tolerance — meaning the same dose no longer produces the same level of relief, and the person may feel they need more of the medication to achieve the same effect [15]. So, when the amount of benzodiazepine in the body drops — for example, if someone takes their dose later than usual or tries to reduce it — the brain can suddenly feel “overactive.” This can lead to uncomfortable symptoms such as anxiety, restlessness, shaking, or trouble sleeping. Because of this, stopping or lowering the medication can feel very difficult, even when the person truly wants to [16]. These symptoms are clear signs that the body has become reliant on the drug to maintain neurochemical balance.

2. Psychological Dependence

Psychological dependence happens when the mind believes the medication is essential for coping, even when the body may no longer physically need it. This type of dependence tends to be more prominent with long-term or high-dose use. People often develop a strong emotional attachment to benzodiazepines. They may feel they need the drug to manage anxiety, sleep, or simply get through daily stress. Even after physical withdrawal fades, cravings and fear can linger for months. Thoughts like: “I just can’t sleep without my pill,” or “I’ll panic if I don’t take it,” can become automatic, trapping the person between fear and the desire for relief. It usually starts with good intentions — someone goes through a difficult period, like a breakup, health scare, or major life change, and their doctor prescribes a benzodiazepine. The first time they take it, they feel an almost magical calm: the racing thoughts stop, the body relaxes. Over time, the brain learns that this pill is the “off switch” for anxiety or sleeplessness. Soon, facing stress or sleeping without it feels impossible. That’s how psychological dependence grows — not from weakness, but from the brain’s natural need for comfort, predictability, and emotional safety. The drug becomes a trusted coping tool, and letting go can feel like losing control over one’s peace of mind [17], [18].

Breaking Free: A Slow and Gentle Process

Recovery from benzodiazepine dependence — especially the psychological kind — takes time. It’s not a race, but a gradual process best done slowly and under professional guidance. The goal isn’t simply to stop the medication, but to help the mind and body regain a sense of safety without it. This is why tapering under professional supervision is so important. Instead of stopping suddenly, the dose is reduced slowly in small steps, giving the nervous system time to adapt and preventing the overwhelming rebound anxiety that can happen with abrupt withdrawal. Along the way, therapeutic support — such as cognitive-behavioral therapy (CBT) — helps rebuild confidence and develop healthier, long-term coping strategies [3]. Mindfulness, breathing techniques, and relaxation exercises can further strengthen the body’s natural ability to self-soothe, showing the brain that calm is still possible without the drug. Just as vital is social support; being understood, encouraged, and accepted makes the process feel less frightening and more manageable [3], [19]. Recovery is not about eliminating anxiety completely, but learning to approach it with patience, resilience, and trust in one’s own ability to handle difficult moments. Over time, individuals learn to recognize anxiety not as an emergency, but as a temporary state that will pass. Sleep, which may feel impossible at first, gradually becomes more natural as routines stabilize and the mind begins to trust its own rhythms again. Small victories — like facing a stressful moment without reaching for a pill — slowly rebuild self-belief.

Picture 3.

Compassion Over Judgment

Psychological dependence on benzodiazepines isn’t about weakness — it’s about how human beings learn to protect themselves. For someone who has lived with anxiety or trauma, the medication becomes more than a pill; it becomes a symbol of safety. Over time, that safety net can feel indispensable, and even the thought of letting go can trigger fear or panic. The mind learns to associate calm with the pill and anxiety with its absence. When tapering begins, it can feel like taking off armor you didn’t realize you were wearing.

At the same time, society sends mixed messages: we are encouraged to “take care of our mental health,” yet warned against becoming “dependent.” This contradiction fuels shame, silence, and hesitation to seek guidance. But recovery is not something that should be attempted alone. Reaching out to healthcare professionals, therapists, or support groups is a sign of strength, not failure, and can provide a safer, steadier path forward. Breaking the stigma around medication dependence is essential — people need compassion, information, and support, not judgment.

Equally important is greater awareness among prescribers. Clinicians may not always have time, training, prescribing guidelines, policies, and a monitoring system to support alternatives to medication, so in many cases, renewals can become routine. Encouraging more cautious prescribing, regular follow-up, and informed discussions about long-term risks can prevent dependence from forming in the first place.

Breaking free takes patience, empathy, and professional guidance. It’s not just about letting go of a medication, but about rebuilding trust in oneself — trust that calm can come from within, not only from a pill. And if you or someone you love feels stuck, know this: healing is possible. Recovery doesn’t mean never feeling anxious again — it means learning to live with that anxiety without fear. When that happens, calm is no longer a cage. It becomes freedom.

Bibliography

[1] F. López-Muñoz, C. Álamo, and P. García-García, “The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: Half a century of anxiolytic drugs,” Journal of Anxiety Disorders, vol. 25, no. 4, pp. 554–562, May 2011, doi: 10.1016/j.janxdis.2011.01.002.

[2] Kaiser Permanente Washington., “Benzodiazepine and Z-Drug Safety Guideline.” Kaiser Permanente Washington, 2022. Accessed: Sep. 10, 2025. [Online]. Available: https://wa.kaiserpermanente.org/static/pdf/public/guidelines/benzo-zdrug...

[3] ASAM el al, “Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations when Benzodiazepine Risks Outweigh Benefits.” ASAM, 2025.

[4] D. T. Maust, L. A. Lin, and F. C. Blow, “Benzodiazepine Use and Misuse Among Adults in the United States,” PS, vol. 70, no. 2, pp. 97–106, Feb. 2019, doi: 10.1176/appi.ps.201800321.

[5] Weltgesundheitsorganisation, Ed., The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines, Reprinted. Geneva: World Health Organization, 2009.

[6] H. Taipale et al., “Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland,” JAMA Netw Open, vol. 3, no. 10, p. e2019029, Oct. 2020, doi: 10.1001/jamanetworkopen.2020.19029.

[7] T. A. T. Kurko et al., “Long-term use of benzodiazepines: Definitions, prevalence and usage patterns – a systematic review of register-based studies,” Eur. psychiatr., vol. 30, no. 8, pp. 1037–1047, Nov. 2015, doi: 10.1016/j.eurpsy.2015.09.003.

[8] S. Billioti De Gage et al., “Benzodiazepine use and risk of Alzheimer’s disease: case-control study,” BMJ, vol. 349, no. sep09 2, pp. g5205–g5205, Sep. 2014, doi: 10.1136/bmj.g5205.

[9] K. E. Ensrud et al., “Central Nervous System–Active Medications and Risk for Falls in Older Women,” J American Geriatrics Society, vol. 50, no. 10, pp. 1629–1637, Oct. 2002, doi: 10.1046/j.1532-5415.2002.50453.x.

[10] L. Orriols et al., “Road traffic crash risk associated with benzodiazepine and z‐hypnotic use after implementation of a colour‐graded pictogram: a responsibility study,” Brit J Clinical Pharma, vol. 82, no. 6, pp. 1625–1635, Dec. 2016, doi: 10.1111/bcp.13075.

[11] C.-F. Sun, A. S. Pola, K.-P. Su, B. Y. Lin, A. S. Kablinger, and R. L. Trestman, “Benzodiazepine use for anxiety disorders is associated with increased long-term risk of mood and substance use disorders: A large-scale retrospective cohort study,” Drug and Alcohol Dependence Reports, vol. 12, p. 100270, Sep. 2024, doi: 10.1016/j.dadr.2024.100270.

[12] S. El Hayek, V. Lasebikan, and A. Noroozi, “Editorial: Alcohol and drug use in low- and middle-income countries,” Front. Psychiatry, vol. 15, p. 1381726, Feb. 2024, doi: 10.3389/fpsyt.2024.1381726.

[13] C. P. O’brien, “Benzodiazepine use, abuse, and dependence,” J Clin Psychiatry, vol. 66 Suppl 2, pp. 28–33, 2005.

[14] Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD., “Benzodiazepine pharmacology and central nervous system-mediated effects”.

[15] M. C. Gravielle, “Effect of Chronic Benzodiazepine Exposure on GABA A Receptors,” in Neuropathology of Drug Addictions and Substance Misuse, Elsevier, 2016, pp. 308–316. doi: 10.1016/B978-0-12-800634-4.00030-5.

[16] C. Vicens et al., “Withdrawal from long-term benzodiazepine use: randomised trial in family practice,” Br J Gen Pract, vol. 56, no. 533, pp. 958–963, Dec. 2006.

[17] S. Burmester, C. Krüger, J. Franck, M. H. Lindberg, and J. Westman, “At the tipping point: Patient experiences of addiction to benzodiazepines and motivation to seek treatment,” Journal of Substance Use and Addiction Treatment, vol. 167, p. 209508, Dec. 2024, doi: 10.1016/j.josat.2024.209508.

[18] A. Konopka, J. Pełka-Wysiecka, A. Grzywacz, and J. Samochowiec, “Psychosocial characteristics of benzodiazepine addicts compared to not addicted benzodiazepine users,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 40, pp. 229–235, Jan. 2013, doi: 10.1016/j.pnpbp.2012.09.001.

[19] D. Zeraatkar et al., “Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis,” BMJ, vol. 389, p. e081336, Jun. 2025, doi: 10.1136/bmj-2024-081336.